ARCHIVES

US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara

This article is from The Cancer Letter archive.

Vol. 23 No. 01 | January 10, 1997

Download PDF Visit The Full Archive

Related Articles

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable

January 31, 2003

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995

Female Smokers Face Double Risk For Lung Cancer

July 28, 2006

Montefore Oncology Dept. Writes In Support of Peter Wiernik

November 12, 1993

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983